Target

glycinamide ribonucleotide formyltransferase

24 products, 17 indications

Indications
metastatic non-small cell lung cancer (5 products)
NSCLC (5 products)
advanced non-squamous NSCLC (3 products)
EGFRm+ NSCLC with CNS metastasis (3 products)
EGFR ex20ins-mutant NSCLC (3 products)
KRAS G12C-mutated solid tumors (1 products)
NSCLC with leptomeningeal metastases (1 products)
EGFR-mutated, c-Met overexpressing NSCLC (1 products)
stage 4 non-squamous non-small cell lung cancer (1 products)
Unresectable stage III non-small cell lung cancer (1 products)
Non-Small Cell Lung Cancer (1 products)
unresectable stage 3 NSCLC (1 products)
unresectable stage IIIA/IIIB NSCLC (1 products)
Locally advanced non-small cell lung cancer (1 products)
Advanced NSCLC with EGFR mutation (1 products)
Platinum-resistant recurrent ovarian carcinoma (1 products)
Ovarian Cancer (1 products)
Loading...

1 drug